DailySpaceBursa Malaysia companies, read from their annual reports从年报读懂大马上市公司

TOPVISION EYE SPECIALIST BERHAD

0332 · ACE Market创业板(ACE Market) · annual reports 2024 to 2025, 904 entries read2024 至 2025 年报,共读出 904 条

Revenue, 20252025 年营业额RM45.8m4.58千万令吉up 3.7% from比 2024 年增加 3.7%,当年为 RM44.2m4.42千万令吉 in 2024
Profit for the financial year, 20252025 年本财政年度盈利RM1.99m199万令吉up 93.2% from比 2024 年增加 93.2%,当年为 RM1.03m103万令吉 in 2024
Net cash from operating activities, 20252025 年营运活动所得现金净额RM7.82m782万令吉down 7.9% from比 2024 年减少 7.9%,当年为 RM8.49m849万令吉 in 2024
Borrowings including lease liabilities, 20252025 年借款,包括租赁负债RM27.7m2.77千万令吉up 3.6% from比 2024 年增加 3.6%,当年为 RM26.7m2.67千万令吉 in 2024

The company这家公司

TOPVISION provides ophthalmology services and related medical consultancy, and markets eye supplements and health food products. The group operates in Malaysia and reports its business as a single segment. Its operating network expanded from 11 to 13 ambulatory care centres in 2025.TOPVISION 提供眼科服务及相关医疗咨询,并销售眼部营养补充剂与健康食品。集团在马来西亚经营,将业务列为单一报告分部。2025 年,营运中的日间医疗中心由 11 家增至 13 家。

Source: annual report 2025, pages 45, 149.出处:2025 年年报第 45、149 页。

No customer contributed 10% or more of total revenue. In 2024, local patients accounted for 98.19% of revenue and foreign patients 1.81%.没有客户占总营业额的 10% 或以上。2024 年,本地患者占营业额 98.19%,外国患者占 1.81%。

Source: annual report 2024, page 17; annual report 2025, pages 143, 149.出处:2024 年年报第 17 页;2025 年年报第 143、149 页。

The 2025 list of thirty largest holders records DATUK DR. KENNY LIEW HOCK NEAN with 118,237,571 shares, or 38.163%, and DR. ANGELA LOO VOON PEI with 14,938,089 shares, or 4.821%. Datuk Dr. Kenny is the husband of Dr. Angela, a consultant ophthalmologist. Chief Executive Officer and Executive Director Dr. Peter Chong is the husband of Carolyn Soong Yoke Voon, the Chief Operating Officer.2025 年三十大股东名单列出 DATUK DR. KENNY LIEW HOCK NEAN 持有 118,237,571 股,占 38.163%;DR. ANGELA LOO VOON PEI 持有 14,938,089 股,占 4.821%。Datuk Dr. Kenny 是眼科顾问医生 Dr. Angela 的丈夫。首席执行员兼执行董事 Dr. Peter Chong 是首席营运员 Carolyn Soong Yoke Voon 的丈夫。

Source: annual report 2025, pages 23, 24, 28, 159.出处:2025 年年报第 23、24、28、159 页。

The 2025 largest-holder list also records PUBLIC NOMINEES (TEMPATAN) SDN BHD pledged securities accounts for PETER CHONG KUOK SIONG with 53,825,173 shares (17.373%); GAN CHEE CHONG with 6,950,301 shares (2.243%); CHONG ZYH SIONG with 1,638,246 shares (0.528%); PHANG YEEN NUNG with 1,500,000 shares (0.484%); and PHANG YEEN HUNG with 1,209,400 shares (0.390%).2025 年大股东名单也列出 PUBLIC NOMINEES (TEMPATAN) SDN BHD 名下的抵押证券账户:PETER CHONG KUOK SIONG 为 53,825,173 股(17.373%);GAN CHEE CHONG 为 6,950,301 股(2.243%);CHONG ZYH SIONG 为 1,638,246 股(0.528%);PHANG YEEN NUNG 为 1,500,000 股(0.484%);PHANG YEEN HUNG 为 1,209,400 股(0.390%)。

Source: annual report 2025, page 159.出处:2025 年年报第 159 页。

Dr. Azida Juana Binti Wan Ab Kadir joined the board on 3 January 2024. Lee Geok Ai joined on 1 October 2024. The board approved the change of external auditors to TGS TW PLT on 29 August 2025.Dr. Azida Juana Binti Wan Ab Kadir 于 2024 年 1 月 3 日加入董事会。Lee Geok Ai 于 2024 年 10 月 1 日加入。董事会于 2025 年 8 月 29 日批准更换外部审计师为 TGS TW PLT。

Source: annual report 2024, pages 20, 23, 59; annual report 2025, page 99.出处:2024 年年报第 20、23、59 页;2025 年年报第 99 页。

Revenue by type, 20252025 年营业额构成

Services rendered: 85.8%Sales of goods: 14.2%
Services rendered 85.8%提供服务 85.8%Sales of goods 14.2%商品销售 14.2%

Source: annual report 2025, page 143.出处:2025 年年报第 143 页。

Major events大事记

2023On 4 July, the company incorporated TESC-M, its Mentakab subsidiary, with RM100,000 of paid-up capital.7 月 4 日,公司成立 Mentakab 子公司 TESC-M,缴足资本为 RM100,000。

Source: annual report 2024, pages 108, 110.出处:2024 年年报第 108、110 页。

2024TOPVISION expanded to Mentakab in August, describing it as its eleventh ambulatory care centre.TOPVISION 于 8 月扩展至 Mentakab,将其列为第十一家日间医疗中心。

Source: annual report 2024, page 12.出处:2024 年年报第 12 页。

2024The transfer from the LEAP Market to the ACE Market was completed on 16 December. The transfer listing exercise included issuing 54,220,000 new shares at RM0.33 each, raising RM17.9 million.12 月 16 日,公司完成由 LEAP Market 转至 ACE Market。转板上市计划包括以每股 RM0.33 发行 54,220,000 股新股,筹集 RM17.9 million。

Source: annual report 2024, pages 15, 78.出处:2024 年年报第 15、78 页。

2025On 6 February, Topwellness Healthcare Sdn Bhd incorporated Megapharma Sdn Bhd as a 51%-owned subsidiary, subscribing RM51,000 for 51,000 shares.2 月 6 日,Topwellness Healthcare Sdn Bhd 成立持股 51% 的子公司 Megapharma Sdn Bhd,以 RM51,000 认购 51,000 股。

Source: annual report 2024, page 135.出处:2024 年年报第 135 页。

2025Kuala Terengganu obtained its Ministry of Health clinic licence on 5 May and began operations on 1 June.Kuala Terengganu 于 5 月 5 日取得卫生部诊所执照,并于 6 月 1 日开始营运。

Source: annual report 2025, page 18.出处:2025 年年报第 18 页。

2025Tawau obtained its licence on 14 August and began operations on 2 September.Tawau 于 8 月 14 日取得执照,并于 9 月 2 日开始营运。

Source: annual report 2025, page 18.出处:2025 年年报第 18 页。

Revenue, profit and operating cash营业额、盈利与营运现金

Revenue营业额
2023
RM43.0m4.30千万令吉
2024
RM44.2m4.42千万令吉
2025
RM45.8m4.58千万令吉
Profit for the financial year本财政年度盈利
2023
RM4.82m482万令吉
2024
RM1.03m103万令吉
2025
RM1.99m199万令吉
Net cash from operating activities营运活动所得现金净额
2023
RM8.33m833万令吉
2024
RM8.49m849万令吉
2025
RM7.82m782万令吉

Assets, borrowings and equity资产、借款与权益

Total assets总资产
2023
RM50.2m5.02千万令吉
2024
RM78.9m7.89千万令吉
2025
RM75.4m7.54千万令吉
Borrowings including lease liabilities借款,包括租赁负债
2023
RM16.7m1.67千万令吉
2024
RM26.7m2.67千万令吉
2025
RM27.7m2.77千万令吉
Total equity总权益
2023
RM30.0m3.00千万令吉
2024
RM47.8m4.78千万令吉
2025
RM43.8m4.38千万令吉

Cash balances and short-term investments现金结余与短期投资

Cash and bank balances现金与银行结余
2023
RM6.57m657万令吉
2024
RM10.1m1.01千万令吉
2025
RM10.7m1.07千万令吉
Short-term investments短期投资
2023
RM3.10m310万令吉
2024
RM15.2m1.52千万令吉
2025
RM6.95m695万令吉

20242024 年

Operations brought in RM8.5 million and cash purchases of property, plant and equipment used RM12.3 million. The share issue brought in RM16.6 million after issuance expenses. The group drew RM5.7 million of term loans, repaid RM574,898 of term loans and RM1.3 million of lease liabilities, and paid RM1.2 million of interest. It received RM210,000 from transferring subsidiary shares to non-controlling interests. Subsidiaries paid RM70,000 of dividends to non-controlling interests; no dividend was paid to the company's shareholders.营运带来 RM8.5 million,现金购买物业、厂房与设备用了 RM12.3 million。发行股份扣除发行费用后带来 RM16.6 million。集团提取 RM5.7 million 定期贷款,偿还 RM574,898 定期贷款及 RM1.3 million 租赁负债,并支付 RM1.2 million 利息。转让子公司股份予非控股股东带来 RM210,000。子公司向非控股股东支付 RM70,000 股息;公司没有向自身股东支付股息。

Source: annual report 2024, pages 94, 95.出处:2024 年年报第 94、95 页。

20252025 年

Operations brought in RM7.8 million and cash purchases of property, plant and equipment used RM6.5 million. The group drew RM1.5 million of term loans, repaid RM1.8 million of term loans and RM1.6 million of lease liabilities, and paid RM1.6 million of interest. Shareholders received RM6.2 million of dividends and non-controlling interests received RM82,250. Transfers of subsidiary shares brought in RM210,000, while share issues by a subsidiary to non-controlling interests brought in RM68,600. The company issued no shares during the year.营运带来 RM7.8 million,现金购买物业、厂房与设备用了 RM6.5 million。集团提取 RM1.5 million 定期贷款,偿还 RM1.8 million 定期贷款及 RM1.6 million 租赁负债,并支付 RM1.6 million 利息。股东收到 RM6.2 million 股息,非控股股东收到 RM82,250。转让子公司股份带来 RM210,000,子公司向非控股股东发行股份带来 RM68,600。公司年内没有发行股份。

Source: annual report 2025, pages 106, 121, 122.出处:2025 年年报第 106、121、122 页。

Across the years跨年合看

Borrowings including lease liabilities rose from RM16.7 million in 2023 to RM26.7 million in 2024 and RM27.7 million in 2025. Term loans fell from RM12.2 million to RM11.8 million, while lease liabilities rose from RM14.5 million to RM15.8 million. Cash and bank balances rose from RM10.1 million to RM10.7 million in 2025. Short-term investments fell from RM15.2 million to RM7.0 million, and total equity fell from RM47.8 million to RM43.8 million.包括租赁负债的借款由 2023 年 RM16.7 million 增至 2024 年 RM26.7 million,再增至 2025 年 RM27.7 million。定期贷款由 RM12.2 million 降至 RM11.8 million,租赁负债则由 RM14.5 million 增至 RM15.8 million。2025 年,现金与银行结余由 RM10.1 million 增至 RM10.7 million。短期投资由 RM15.2 million 降至 RM7.0 million,总权益由 RM47.8 million 降至 RM43.8 million。

Source: annual report 2024, page 135; annual report 2025, pages 117, 123, 141, 142, 156.出处:2024 年年报第 135 页;2025 年年报第 117、123、141、142、156 页。

Still to be spent尚待支出

At the end of 2025, authorised and contracted building construction and renovation commitments were RM732,202, compared with RM4.6 million a year earlier. The proceeds table showed RM4.7 million still unused for TOPVISION International Eye Specialist Centre. The allocations for Kuala Terengganu and Tawau, medical machines and listing expenses had been used. The property list expected TOPVISION International to be completed and receive its Certificate of Completion and Compliance (CCC) by the third quarter of 2026.2025 年底,已批准并签约的建筑工程及装修承诺为 RM732,202,一年前为 RM4.6 million。募集资金用途表列出 TOPVISION International Eye Specialist Centre 尚有 RM4.7 million 未使用。Kuala Terengganu 与 Tawau、医疗机器及上市费用的拨款已用完。产业清单预计 TOPVISION International 将于 2026 年第三季度前完工并取得竣工及合规证书(CCC)。

Source: annual report 2025, pages 101, 149, 157.出处:2025 年年报第 101、149、157 页。

Four years of figures四年数字

Group figures, in RM, as printed in the statements.集团数字,单位令吉,照财务报表所印。

Group集团202320242025
RM令吉RM令吉RM令吉
Revenue营业额42,958,47944,189,64845,811,205
Profit before tax税前盈利7,514,2463,740,2754,397,799
Profit for the financial year本财政年度盈利4,824,3691,030,2331,990,153
Net cash from operating activities营运活动所得现金净额8,327,3038,485,7027,819,329
Purchase of property, plant and equipment购买物业、厂房与设备(5,002,609)(12,341,980)(6,491,541)
Dividends paid to shareholders已付股东股息(2,044,764)0(6,196,312)
Total assets总资产50,242,81278,880,42575,390,013
Borrowings including lease liabilities借款,包括租赁负债16,694,77826,678,48827,650,200
Cash and bank balances现金与银行结余6,573,03910,094,53010,738,246
Short-term investments短期投资3,103,08415,248,4886,952,332
Total equity总权益30,027,07647,822,23743,812,428

On a computer, hover over a figure for the report and page it is printed on.在电脑上把鼠标移到数字上,可看到它印在哪份年报的哪一页。

Said and done说过的与做到的

What the reports said年报说要做的What later reports show之后年报显示的Status状态
The 2024 report targeted opening the Kuala Terengganu centre in the second quarter of 2025.2024 年报将 Kuala Terengganu 中心的开业目标定在 2025 年第二季度。The 2025 report says it obtained its clinic licence on 5 May and began operations on 1 June 2025.2025 年报表示,该中心于 2025 年 5 月 5 日取得诊所执照,并于 6 月 1 日开始营运。

Source: annual report 2024, page 12; annual report 2025, page 18.出处:2024 年年报第 12 页;2025 年年报第 18 页。

Opened in the target quarter于目标季度开业
The 2024 report targeted opening the Tawau centre in the fourth quarter of 2025.2024 年报将 Tawau 中心的开业目标定在 2025 年第四季度。The centre obtained its licence on 14 August and began operations on 2 September 2025.该中心于 2025 年 8 月 14 日取得执照,并于 9 月 2 日开始营运。

Source: annual report 2024, page 12; annual report 2025, page 18.出处:2024 年年报第 12 页;2025 年年报第 18 页。

Opened before the target quarter早于目标季度开业
The 2024 report said TOPVISION International Eye Specialist Centre was slated to commence operations in the fourth quarter of 2025.2024 年报表示,TOPVISION International Eye Specialist Centre 计划于 2025 年第四季度开始营运。The 2025 report still lists TOPVISION International as under development. It expects completion and issuance of CCC by the third quarter of 2026.2025 年报仍将 TOPVISION International 列为开发中,预计于 2026 年第三季度前完工并取得 CCC。

Source: annual report 2024, page 12; annual report 2025, page 157.出处:2024 年年报第 12 页;2025 年年报第 157 页。

Not open by the stated quarter; completion expected in 2026未于原定季度开业;预计 2026 年完工
The directors recommended a final dividend of 1 sen per share for 2024, subject to shareholders' approval.董事建议就 2024 年派发每股 1 仙终期股息,须经股东批准。The final dividend of RM0.01 per share was declared on 30 June 2025 and paid on 21 July 2025, amounting to RM3.1 million.每股 RM0.01 的终期股息于 2025 年 6 月 30 日宣布,并于 7 月 21 日支付,总额为 RM3.1 million。

Source: annual report 2024, page 78; annual report 2025, page 149.出处:2024 年年报第 78 页;2025 年年报第 149 页。

Paid已支付
The 2024 report planned to expand evacuation training to all branches in 2025, starting with key locations.2024 年报计划于 2025 年从重点地点开始,将疏散训练扩展至所有分行。The 2025 report describes an Emergency Response Plan, internal emergency response training and preparedness training at multiple locations. It does not confirm that evacuation training reached every branch.2025 年报介绍了紧急应变计划、内部紧急应变训练,以及在多个地点开展的应急准备训练,但没有确认疏散训练已覆盖每一家分行。

Source: annual report 2024, page 46; annual report 2025, page 57.出处:2024 年年报第 46 页;2025 年年报第 57 页。

Training reported; full coverage not confirmed已报告训练;未确认全面覆盖

What the reports leave open年报留下待看的事

  • TOPVISION International remains under development. The latest property list expects completion and CCC by the third quarter of 2026; commencement of operations remains to be reported.TOPVISION International 仍在开发中。最新产业清单预计于 2026 年第三季度前完工并取得 CCC;开始营运的情况仍待报告。

    Source: annual report 2025, page 157.出处:2025 年年报第 157 页。

  • The group aims to offer LASIK, Implantable Collamer Lens surgery and aesthetic double eyelid procedures by 2026. The 2025 report presents these as planned offerings.集团目标于 2026 年前提供 LASIK、Implantable Collamer Lens 手术及美容双眼皮手术。2025 年报将这些列为计划推出的服务。

    Source: annual report 2025, page 18.出处:2025 年年报第 18 页。

  • The latest report makes stabilising operations at Mentakab, Kuala Terengganu and Tawau a priority for the coming year. It reports initial losses at Tawau due to startup expenses.最新年报将稳定 Mentakab、Kuala Terengganu 与 Tawau 的营运列为来年的重点,并报告 Tawau 因开办费用而录得初期亏损。

    Source: annual report 2025, pages 16, 21.出处:2025 年年报第 16、21 页。

  • At the end of 2025, five customers each owed more than 10% of group receivables and together accounted for approximately 88% of the outstanding balance. The corresponding figures in 2024 were three customers and 77%.2025 年底,五名客户各自欠款超过集团应收款的 10%,合共约占未收余额的 88%。2024 年相应数字为三名客户及 77%。

    Source: annual report 2025, page 151.出处:2025 年年报第 151 页。

Facts as printed in the company's annual reports, with the page of each; no rating and no advice. Built 2026-10-30.内容为公司年报所印的事实,并注明页码;不评级,不构成投资建议。生成日期 2026-10-30。